Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis

Area of Science:

• Ophthalmology
• Neurology
• Immunology

Background:

• Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease affecting the central nervous system.
• Ocular manifestations, such as uveitis and retinal periphlebitis, can occur in MS patients.
• Interferon beta-1a is a common treatment for multiple sclerosis.

Purpose of the Study:

• To report on the diagnosis and management of intermediate uveitis and retinal periphlebitis in a patient with a long history of multiple sclerosis.
• To discuss the clinical presentation and treatment approach for ocular inflammation in the context of MS therapy.

Main Methods:

• Case report of a 40-year-old female patient with a 12-year history of MS.
• Clinical examination and diagnostic workup for blurred vision and floaters.
• Review of the patient's treatment with interferon beta-1a for 7 years.

Main Results:

• The patient presented with symptoms of intermediate uveitis and retinal periphlebitis.
• Findings related to ocular inflammation were identified and managed.
• The management strategy in the context of ongoing interferon beta-1a therapy was detailed.

Conclusions:

• Intermediate uveitis and retinal periphlebitis can be challenging ocular complications in multiple sclerosis patients.
• Effective management requires a multidisciplinary approach involving neurology and ophthalmology.
• Continued monitoring and tailored treatment are crucial for patients with MS and ocular inflammation.